After a long day of debate, an advisory panel of the US Food and Drug Administration concluded today that it could not endorse the premarket approval (PMA) application for use of the Symplicity Spyral (Medtronic) renal denervation https://yamcode.com/kennedy-says-wants-update-5544 https://yamcode.com/raw/kennedy-says-wants-update-5544 https://yamcode.com/raw/china-president-says-wants-update-1585 https://yamcode.com/china-president-says-wants-update-1585 https://yamcode.com/raw/china-president-says-wants-update-1586 https://yamcode.com/china-president-says-wants-update-1586 https://yamcode.com/raw/kennedy-says-wants-update-1532 https://yamcode.com/kennedy-says-wants-update-1532 https://yamcode.com/raw/macron-says-wants-update-4221-09222023-060029 https://yamcode.com/macron-says-wants-update-4221-09222023-060029 https://yamcode.com/raw/china-president-says-wants-update-1587 https://yamcode.com/china-president-says-wants-update-1587